A previous report from our group had shown in vitro a direct interaction between peroxidases and dietary antioxidants at physiological concentrations, where in the absence of H 2 O 2 , the antioxidants could serve as oxidizing substrates for the peroxidases. However, the physiological relevance of those findings had not been evaluated. The main objective of this study was to determine whether the oxidizing products produced in the interaction between peroxidase and gallic acid at a physiological concentration of 1 μM may promote cell death or survival in a human microvascular endothelial cell line (HMEC-1). Our findings suggested that gallic acid may show a double-edged sword behaviour, since in the absence of H 2 O 2 it may have a pro-oxidant effect which may promote cell injury (evidenced by LDH, Crystal Violet and calcein AM viability/citotoxicity assays), while in the presence of H 2 O 2 , gallic acid may act as an antioxidant inhibiting oxidative species produced in the peroxidase cycle of peroxidases. These observations were confirmed with several oxidative stress biomarkers and the evaluation of the activation of cell survival pathways like AKT and MAPK/ERK.
InTRODuCTIOn
There is now increasing experimental and clinical evidence showing involvement of oxidative stress in the pathogenesis of atherosclerosis (Harrison et al., 2003; Yokoyama, 2004) . It is well known that during endothelial inflammation with activated macrophages several reactive intermediates (e.g., hypochlorus acid, chloramines, tyrosyl radicals and nitrogen dioxide) produced by the interaction between myeloperoxidase (MPO) and hydrogen peroxide may promote the oxidation of lipoproteins (Heinecke, 2003) . Inmunohistochemical assays have shown the presence of MPO in human atherosclerotic lesions, thus implicating them in in vivo LDL modification and atherogenesis (Daugherty et al., 1994) . At least three mechanisms involved in MPO-induced vascular injury responses have been described: consumption of nitric oxide, oxidation of LDL, and reaction with Larginine and protein to produce endogenous nitric oxide synthase inhibitors (Lee et al., 2009; Royet al., 2009; Schindhelm et al., 2009 ). All these mechanisms are hydrogen peroxide-dependent. Therefore, several studies have been undertaken to understand the mechanism of this process and to propose actions that may inhibit the oxidative compounds produced within this system.
In this context, polyphenol intake has been related with the prevention of atherome plaque formation, since they may act as antioxidants and anti-inflammatory agents in vivo (Grassi et al., 2009; Hu, 2009 ). However, their molecular actions in cardiovascular disease prevention are not fully understood yet. It is suggested that flavonoids may act as co-substrates of MPO in the presence of H 2 O 2 , resulting in the formation of oxidized flavonoids possibly by two sequential one-electron reduction steps, generating compound II and the ferric form of MPO (Shiba et al., 2008) . However, the role of those oxidized flavonoids in human pathology is still a focus of discussion. In addition, a strong inhibitory effect of quercetin aglycone on the MPO-catalyzed oxidation reaction has been demonstrated in vitro (Pincemail et al., 1988; Kato et al., 2003) , which may reduce the formation of oxidizing compounds. It has also been demonstrated that gallates may strongly inhibit the enzyme activity, albeit out concentrations higher (around 30 μM to 40 μM) than physiological ones (Kato et al., 2003; Rosso et al., 2006) . On this basis it is plausible that the inhibition of MPO activity by polyphenols might be one mechanism for the prevention of cardiovascular disease.
Nevertheless, even if increasing evidence supports the role of oxidation in atherogenesis, the protective effect of dietary antioxidants in the human is still debated and controversial. The LDL resistance to oxidation does not systematically correlate with its antioxidant content; the degree of lipid peroxidation in atherosclerotic tissue also fails to correlate with the extent of lesion formation, while considerable amounts of antioxidants can be observed in atherosclerotic lesions (Witting et al., 1999) .
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On the basis of this information, the main objective of this study was to determine the physiological implications of the oxidizing products generated in the interaction between peroxidases and gallic acid, at a physiological concentration of 1 μM, in the absence of hydrogen peroxide in a human microvascular endothelial cell line (HMEC-1). Crystal Violet toxicology assay, Calcein AM viability/cytotoxicity assay and lactate dehydrogenase activity were evaluated to determine cell survival under these conditions as well as the activation of AKT and MAPK/ERK cell survival pathways. Furthermore, oxidative stress biomarkers like carbonyl adducts, neuroketals, MDA-lysine adducts and carboxymethyl lysine adducts were determined under this conditions.
MATERIALs AnD METHODs

Materials. Gallic acid monohydrate (328225) and
Crystal Violet (C0775) were purchased from SigmaAldrich. Lactate dehydrogenase (LDH) was measured with the CytoTox 96 ® non-radioactive cytotoxicity assay from Promega (Madison, WI, USA). Calcein AM (C3099) was purchased from Molecular Probes. Horseradish peroxidase (HRP) (A-12216) was purchased from Molecular Probes. Primary antibodies for Western blotting are described in Table 1 . For cell culture, human microvascular endothelial cell line (HMEC-1) was kindly provided by Dr. Anne Négre-Salvayre (INSERM, Toulouse, France). DMEM (BE12-614F) was purchased from BioWhittaker. MEM (51200), FBS (10270-106), penicillin and streptomycin (15140) and l-glutamine (25030) were purchased from Gibco.
Cell culture. HMEC-1 is an immortalized human microvascular endothelial cell line that retains the morphologic, phenotypic, and functional characteristics of normal human microvascular endothelial cells (Ades et al., 1992) . HMEC-1 cells were grown in DMEM supplemented with 10 % fetal bovine serum, 2 mM l-glutamine and penicillin/streptomycin (1 000 U/mL and 1000 μg/L respectively). Cells were maintained at 37 ºC in a humidified atmosphere of 5 % CO 2 . In all experiments cells were grown until confluence and then transferred to 6-or 96-well plates.
Calcein AM viability assay. Calcein AM viability assay is based on the principle that live cells are distinguished by the presence of ubiquitous intracellular esterase activity, determined by the enzymatic conversion of nonfluorescent cell-permeant calcein AM to the intensely fluorescent calcein (excitation/emission 495 nm/515 nm) (Papadopoulus et al., 1994) . For the viability assay HMEC-1 cells were grown until confluence in DMEM 10 % fetal bovine serum and transferred to a 96-well plate and maintained for 24 h in MEM supplemented with 0.5 % fetal bovine serum. Twelve wells were used per experimental treatment which included: control, gallic acid 1 μM, HRP (2 U/mL) + gallic acid 1 μM and each of these three groups with H 2 O 2 (200 μM). All compounds were suspended in MEM without phenol red and without fetal bovine serum. After 24 h of incubation in their corresponding experimental treatment, 100 μL of working solution containing 2 µM calcein AM was added to each well and then incubated at room temperature for 45 min. Fluorescence (excitation/ emission 495/515) was measured for the determination of live cells. Cell viability was determined by comparing the values of calcein fluorescence with those for control cells.
Crystal Violet assay. HMEC-1 cells were cultured and treated following the same procedure employed in the calcein AM viability assay described above. After 24 h of incubation with the corresponding experimental treatment, the medium was removed and cells were washed with 200 µL of PBS and then incubated for 20 min with Crystal Violet (0.2 %). After incubation, plates were rinsed with tap water and 100 µL of sodium dodecyl sulphate (1 %) was added and the absorbance of each well was measured using a microplate reader at 570 nm. Cell viability was determined by comparing the absorbance reading relative to control treatment.
LDH-based toxicity assay. HMEC-1 cells were cultured and treated following the same procedure employed in the calcein AM viability assay described above. After 24 h of incubation with the corresponding experimental treatment, 10 μL of lysis solution was added to 6 of 12 wells in each group, and 10 μL of Hanks balanced solution to the other 6 wells in each group. The wells where Hanks balanced solution was added served to measure the amount of LDH released in the medium, and the wells where the lysis solution was added served to measure the total LDH content (culture-released and intracellular). After 30 min of incubation 50 μL of the supernatant was transferred to an enzymatic assay plate, 50 μL of LDH substrate mix was added and incubated for 30 min at room temp., protected from light. Later 50 μL of stop solution (1 M acetic acid) was added to each well and the absorbance was recorded at 490 nm. Cell viability was measured by relating the content of LDH in the supernatant and to that after lysis.
Analysis of oxidative stress markers and cell survival pathways. Oxidative lesions were evaluated by western blot using anti-DNP (carbonyl adducts formation), N-epsilon-(carboxymethyl) lysine (CML), neuroketal-adducted proteins and malondialdehyde-lysine (MDAlys) adducts. The activation of AKT and MAPK/ERK were used to measure the activation of cell survival pathways. Proteasomal stress was measured by the activa- tion of eIF2α and the degree of protein ubiquitination. HMEC-1 cells were incubated as described above for cell viability determination in 6-well plates. After treatments, cells were lysed using RIPA buffer with protease and phosphatase inhibitors. Protein concentrations were measured using the Lowry assay (BioRad Laboratories, München, Germany) with bovine serum albumin as a standard. Total protein (15-40 μg) was resolved by SDS-PAGE and electroblotted onto polyvinylidene difluoride membranes (Immobilon-P Millipore, Bedford, MA, USA). Immunodetection was performed using as primary and secondary antibodies those listed in Table 1 . A monoclonal antibody to β-actin (Sigma, USA) was used to control protein loading. Protein bands were visualised with the chemiluminescence ECL method (Millipore Corporation, Billerica, MA, USA). Luminescence was recorded and quantified in a Lumi-Imager equipment (Boehringer, Mannheim, Germany), using the Quantity One 4.6.5. software.
Statistical analysis.
All statistics were performed using the SPSS software (SPSS Inc., Chicago, IL, USA). Differences between groups were analyzed by one way Anova. The 0.05 level was selected as the point of minimal statistical significance in every comparison.
REsuLTs
In vitro toxicity assays
Three in vitro toxicity assays were employed to asses the effects of oxidative agents produced by the interaction of peroxidase and gallic acid as shown in Fig. 1 . The experimental model included the incubation of HMEC-1 cells for 24 h with gallic acid (1 μM) and its combination with HRP peroxidase in the presence or absence of H 2 O 2 . The three viability/toxicity assays employed showed almost the same results. In all cases, gallic acid seem to induce cell survival/proliferation, while HRP did not induce any effect on cell survival/proliferation as observed by the calcein AM and LDH toxicity assay. It is also evidenced that the protecting effect of gallic acid in HMEC-1 cells could be counteracted by the incorporation of HRP peroxidase in the system.
As negative controls cells were cultured with high amounts of H 2 O 2 (200 μM) to induce cell injury. In the three viability/toxicology assays tested the cell viability was reduced considerably by the addition of H 2 O 2 to the medium (Fig. 1) . The addition of HRP or gallic acid inhibited the cell injury induced by H 2 O 2 , however, their beneficial effects were lost when both HRP and gallic acid were added.
MAPK/ERK and AKT pathway analysis
Cell survival pathways were assessed to confirm the results obtained by the toxicity assays. The MAPK/ ERK pathway is a signal transduction pathway that couples intracellular responses to the binding of growth factors to cell surface receptors. In the same manner, AKT is involved in cellular survival pathways, by inhibiting apoptotic processes. Results from the analysis of these pathways are shown in Fig. 2 . As controls for the inhibition of these pathways, the incubation of the cell line under high concentration of H 2 O 2 (200 μM) which is assumed to induce cell death was employed. The activity of both pathways was reduced considerably under the treatment with H 2 O 2 . Under the experimental conditions studied, the treatment with gallic acid and HRP combined in the absence of H 2 O 2 reduced considerably the activation of both cell survival pathways, which resembles the results obtained in cell toxicology assays. The inhibition of the MAPK/ERK pathway by gallic acid + HRP peroxidase was similar to the inhibition observed in the control group exposed to high concentration of H 2 O 2 (200 μM) and with a major extent reduction in the AKT pathway signalling.
Oxidative stress biomarkers
Oxidative stress is also known to induce apoptosis in a variety of cell types by activating intracellular cell death signalling cascades (Martindale & Holbrook, 2002) . The purpose of assessing oxidative stress was A B C to determine if the observed effects in the loss of cell survival could be attributed to the oxidative damage produced by the interaction between HRP and gallic acid. Four oxidative stress biomarkers were assessed as shown in Fig. 3 . The results obtained were similar to those of the toxicity assays and cell survival pathways in the case of three (CML, MDA-lys and neuroketals) of the four stress biomarkers assessed. The experimental conditions (gallic acid + HRP, gallic acid + HRP + H 2 O 2 , and control+H 2 O 2 ) that caused a high oxidative stress showed also a high cell death rate and a poor activation of cell survival pathways. Anti-DNP immunoreactivity showed different results in relation to CML, MDA-lys and neuroketals oxidative stress biomarkers principally because it was observed a different oxidized protein pattern between treatments (Fig. 4) where an increase in specifics proteins oxidation was detected. Anti-ubiquitin and eIF2α immunoreactivy was also evaluated to determine the rate of protein turnover, principally to determine whether or not the degree of oxidated protein could be due to accumulation of damaged proteins because of a lower proteosomal activity (Fig. 5) . The grade of protein ubiquitination was higher when H 2 O 2 was present as well as when gallic acid was added in combination with HRP. Increased eIF2α phosphorylation, also observed under the latter condition, indicates high endoplasmatic reticulum stress which may lead to an impairment of the ubiquitin-proteosomal activity. MAPK/ERK (A) and AKT (B) pathways were analysed. Activation of these pathways is expressed as an increase in the amount of phospho-MAPK/ERK and phospho-AKT in relation to the total amount of MAPK/ERK and AKT, respectively. Same letters between columns shows no statistically significant differences between groups (P > 0.05). A B
